Join to view full profile
1475 NW 12th AveMiami, FL 33136
Phone+1 305-243-6604
Fax+1 305-243-4905
Dr. Welsh is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1994 - 1997
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1988- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1984 - 1987
Virginia Commonwealth University School of MedicineClass of 1984
Certifications & Licensure
FL State Medical License 1995 - 2027
OH State Medical License 1988 - 1998
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top Doctors:South Florida Castle Connolly, 2012
Clinical Trials
Publications & Presentations
PubMed
- 88 citationsPhase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical...Alberto J. Montero, Claudia Marcela Diaz-Montero, Y. E. Deutsch, Judith Hurley, Leonidas G. Koniaris
Breast Cancer Research and Treatment. 2012-02-01 - 60 citationsFinal results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancerC. Lobo, Gilberto Lopes, Odalys Baez, Aurelio Castrellon, Annapoorna Ferrell
Breast Cancer Research and Treatment. 2010-06-29 - 11 citationsA Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-nega...Orlando Silva, Gilberto Lopes, Daniel Morgenzstern, C. Lobo, Philomena Doliny
Clinical Breast Cancer. 2008-04-01
Press Mentions
Woman to WomanMay 13th, 2021
Grant Support
- RHO Gtpase And Cell Cycle Regulation In Breast CancerNational Cancer Institute2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
